Drugs / Allogeneic Human CSps
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01496209 | Jul 2015 → Sep 2017 | cardiomyopathy | Cedars-Sinai Medical Center | Withdrawn | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic Human CSps | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01496209 ↗ |
| Known as | Allogeneic Human Cardiospheres | “Allogeneic Human Cardiospheres (allogeneic CSps or alloCSps), a 3D micro-tissue heart-derived cell therapy product” NCT01496209 ↗ |
| Modality | Cell therapy | “a 3D micro-tissue heart-derived cell therapy product” NCT01496209 ↗ |
| Route | Other | “via endomyocardial injection” NCT01496209 ↗ |